Dose Effects of Recombinant Human lnterleukin-6 on Pituitary Hormone Secretion and Energy Expenditure
The DOI matches its Crossref record.
Abstract
Interleukin-6 (IL-6), the main circulating cytokine, is putatively a major mediator of the effects of the immune system on several endocrine axes and intermediate metabolism. We performed dose-response studies of recombinant human IL·6 on pituitary hormone secretion in 15 healthy male volunteers, using 5 single, escalating subcutaneous doses of IL-6 (0.1, 0.3, 1.0, 3.0 and 10.0 µg/kg body weight), each in 3 volunteers. We measured resting metabolic rate (RMR) with indirect calorimetry and plasma anterior pituitary hormones and vasopressin (AVP) at baseline and half-hourly over 4 h after the injection. All doses examined were tolerated well and produced no significant adverse effects. Dose-dependent RMR increases were observed in response to the 3.0- and 10.0-µg/kg doses of IL-6, beginning at 60 min and slowly peaking between 180 and 240 min. Plasma adrenocorticotropic-hormone concentrations increased dramatically and dose-dependently in all the patients who received the 3.0- and 10.0-µg/kg doses of IL-6, respectively, peaking to 150 and 255 pg/ml at 60 min, and slowly returning to normal by 4 h. Corresponding plasma cortisol levels peaked dose-dependently between 90 and 150 min, but remained elevated throughout the sampling period. In contrast, the growth hormone (GH) dose-response was bell-shaped, with maximum (approximately 100-fold) stimulation achieved by 3.0 µg/kg IL-6. Prolactin (PRL) showed a similar but less pronounced response pattern. Thyroid-stimulating hormone (TSH) dose-dependently and progressively decreased over the 240 min, while gonadotropins showed no clear-cut changes. In conclusion, subcutaneous IL-6 administration induced synchronized dose-dependent increases in the RMR and hypothalamic-pituitary-adrenal axis activity, suggesting that hypothalamic corticotropin-releasing hormone may mediate both of these functions in humans. IL-6 also acutely stimulated GH and PRL secretion and suppressed TSH secretion. The dose of 3.0 µg/kg could be used safely in the study of patients with disturbances of the hypothalamic-pituitary unit or of thermogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic smoldering inflammation in humans is already established with elevations of serum IL-6 from normal levels of 1 pg/mL to approximately 10 to 100 pg/mL of serum IL-6, leading to an increase of resting metabolic rate in healthy volunteers [8].”
From Interaction of the endocrine system with inflammation: a function of energy and volume regulation (2014) · cites this paper as [8]
In the citing paper
“In these settings, circulating cytokine levels can be 5 to 10 times higher than normal (e.g., IL-6 from 2 pg/ml to 10–20 pg/ml), and the overall stimulus might be strong enough to induce a mild systemic water retention and energy appeal reaction (responses shown for low IL-6 serum concentrations in ref. [42, 43]).”
From Evolutionary medicine and chronic inflammatory state—known and new concepts in pathophysiology (2012) · cites this paper as [42]
In the citing paper
“the overall stimulus might be strong enough to induce a mild systemic water retention and energy appeal reaction (responses shown for low IL-6 serum concentrations in ref. [42, 43]).”
From Evolutionary medicine and chronic inflammatory state—known and new concepts in pathophysiology (2012) · cites this paper as [42]
In the citing paper
“IL-6 and TNF-α stimulate secretion of cortisol and, in turn, cortisol inhibits their secretion.84”
From Interacting epidemics? Sleep curtailment, insulin resistance, and obesity (2012) · cites this paper as [84]
Citations
Cited by
Items 101–200 of 224
HIV-1 Infection and its Impact on the HPA Axis, Cytokines, and Cognition
Kumar, M., Kumar, A. M., Waldrop, D. G., Antoni, M. H., & Eisdorfer, C. (2003) · Stress · doi:10.1080/10253890310001605376 · Cited by 43
“In human beings it has been shown that IL-6 administration increases ACTH secretion as well, followed by an increase in the levels of cortisol (Tsigos et al., 1997).”
BackgroundGlucocorticoid withdrawal syndrome: what to expect and how to manage
Theiler‐Schwetz, V., & Prete, A. (2023) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000804 · Cited by 49
The therapeutic potential of interleukin-6 in treating obesity
Wallenius, K., Jansson, J.-O., & Wallenius, V. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.7.1061 · Cited by 42
“The authors and others have reported that IL-6 stimulates energy expenditure in experimental animals [7,49] and in humans [50,58].”
BackgroundLutz, S. Z., Hennige, A. M., Feil, S. C., Peter, A., Gerling, A., Machann, J., Kröber, S. M., Rath, M., Schürmann, A., Weigert, C., et al. (2011) · Diabetes · doi:10.2337/db10-0760 · Cited by 45
“Moreover, administration of IL-6 to human volunteers induced higher energy expenditure (49) and elevated fasting blood glucose levels (50).”
Turner, D. G. P., Gray, B. J., Luzio, S. D., Dunseath, G. J., Bain, S. C., Hanley, S. J., Richards, A., Rhydderch, D. C., Ayles, M., Kilduff, L. P., et al. (2015) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.12472 · Cited by 43
“The findings from this study suggest that IL-6 did not contribute to any exercise-induced change in BG or alteration in glucocorticoid activity (Tsigos et al., 1997).”
BackgroundThe effect of stress on periodontitis: A clinicobiochemical study
Chava, V. K., & Mannem, S. (2012) · Journal of Indian Society of Periodontology · doi:10.4103/0972-124x.100912 · Cited by 36
“[5,6] When the inflammatory action is sufficiently long and profound, the systemic manifestations of the disease may become evident, as could happen with periodontitis.”
Effect of a High-Fat Meal on the Growth Hormone Response to Exercise in Children
Galassetti, P., Larson, J., Iwanaga, K., Salsberg, S. L., Eliakim, A., & Pontello, A. (2006) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2006.19.6.777 · Cited by 36
Yavropoulou, M. P., Filippa, M. G., Mantzou, A., Ntziora, F., Mylona, M., Tektonidou, M. G., Vlachogiannis, N. I., Paraskevis, D., Kaltsas, G. A., Chrousos, G. P., et al. (2022) · Endocrine · doi:10.1007/s12020-021-02968-8 · Cited by 33
Self-citationFenkçi, S. M., Rota, S., Sabir, N., Sermez, Y., Güçlü, A., & Akdağ, B. (2006) · Journal of Investigative Medicine · doi:10.2310/6650.2006.06010 · Cited by 35
“Both of these cytokines induce insulin resistance.(1,8,9,12,13) The abdominal fat layers comprise subcutaneous, preperitoneal, and visceral fat compartments.”
BackgroundAzzam, M. M., Dong, X., & Zou, X. (2016) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.12559 · Cited by 37
“These pro- inflammatory cytokines are produced and released by macrophages, and they are the primary cellular mes- sengers triggering the cascade of metabolic alterations following the innate immune response (Klasing and Johnstone, 1991; Tsigos et al., 1997).”
BackgroundA Prospective Study of Tender Points and Fibromyalgia During and After an Acute Viral Infection
Rea, T. D., Russo, J. E., Katon, W. J., Ashley, R. L., & Buchwald, D. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.8.865 · Cited by 31
“Thus, perhaps an FM-like syndrome is unveiled in febrile subjects through the production of acute-phase reactants, such as interleukin 6, that are known to cause fever and induce fatigue.(49,50) Although the findings are not readily understood, other studies in both general and clinic populations have consistently obs…”
BackgroundNeuroendocrine responses to running in women after zinc and vitamin E supplementation
SINGH, A., PAPANICOLAOU, D. A., LAWRENCE, L. L., HOWELL, E. A., CHROUSOS, G. P., & DEUSTER, P. A. (1999) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199904000-00007 · Cited by 32
Self-citationDermitzaki, E., Liapakis, G., Androulidaki, A., Venihaki, M., Melissas, J., Tsatsanis, C., & Margioris, A. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097060 · Cited by 33
Neuroendocrine-immune interactions in the neonate
Matteri, R. L., Klir, J. J., Fink, B. N., & Johnson, R. W. (1998) · Domestic Animal Endocrinology · doi:10.1016/s0739-7240(98)00024-1 · Cited by 31
8 Acquired growth hormone resistance in adults
Jenkins, R. C., & Ross, R. J. M. (1998) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(98)80025-6 · Cited by 30
Hiscock, N., Fischer, C. P., Sacchetti, M., van Hall, G., Febbraio, M. A., & Pedersen, B. K. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00274.2004 · Cited by 30
“Growth hormone has been shown to be increased in some (21), but not all (16), rhIL-6 infusion studies and is known to be a strong regulator of lipolysis (12).”
BackgroundEffect of rhIL-6 infusion on GH→IGF-I axis mediators in humans
Nemet, D., Eliakim, A., Zaldivar, F. P., & Cooper, D. M. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00053.2006 · Cited by 31
“Our study confirmed earlier observations that IL-6 infusion leads to increased circulating GH (39).”
BackgroundResultYamagata, A. S., Mansur, R. B., Rizzo, L. B., Rosenstock, T. R., McIntyre, R. S., & Brietzke, E. M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.11.010 · Cited by 33
Kelsven, S., de la Fuente‐Sandoval, C., Achim, C. L., Reyes-Madrigal, F., Mirzakhanian, H., Domingues, I., & Cadenhead, K. S. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.01.003 · Cited by 30
Protein and Overtraining: Potential Applications for Free-Living Athletes
Lowery, L. M., & Forsythe, C. E. (2006) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-3-1-42 · Cited by 39
Borghetti, P., Saleri, R., Ferrari, L., Morganti, M. M., Angelis, E. D., Franceschi, V., Bottarelli, E., & Martelli, P. R. (2010) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2010.06.004 · Cited by 34
Effects of dietary L-isoleucine on laying performance and immunomodulation of laying hens
Dong, X., Azzam, M. M., & Zou, X. (2016) · Poultry Science · doi:10.3382/ps/pew163 · Cited by 32
Leptin and the Adipocyte Endocrine System
Diamond, F., & Eichler, D. C. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360290795565 · Cited by 29
Demir, H., Tanrıverdi, F., Özoğul, N., Çalış, M., Kırnap, M., Durak, A. C., & Keleştimur, F. (2006) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740500474586 · Cited by 24
“This was clearly demonstrated in the study by Tsigos et al (21).”
ResultEffects of experimental panic on neuroimmunological functioning
van Duinen, M. A., Schruers, K. R. J., Kenis, G., Wauters, A., Delanghe, J., Griez, E. J. L., & Maes, M. H. J. (2008) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2007.10.004 · Cited by 27
“In fact, IL-6, for example, stimulates HPA-axis activity at concentrations known to occur in human plasma [50,51].”
BackgroundDensem, C. G., Ray, M., Hutchinson, I. V., Yonan, N. A., & Brooks, N. H. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.03.016 · Cited by 24
Further evidence for insufficient hypothalamic-pituitary-glandular axes in polymyalgia rheumatica.
Straub, R. H., & Cutolo, M. (2006) · PubMed · Cited by 27
Straub, R. H. (2002) · British journal of rheumatology · doi:10.1093/rheumatology/41.4.423 · Cited by 22
Rovenský, J., Blažíčková, S., Rauová, L., Ježová, D., Koška, J., LUKÁČ, J., & Vigas, M. (1998) · Lupus · doi:10.1191/096120398678920325 · Cited by 23
The role of exercise on the innate immunity of the elderly
Malaguarnera, L., Cristaldi, E., Vinci, M., & Malaguarnera, M. (2007) · European Review of Aging and Physical Activity · doi:10.1007/s11556-007-0028-8 · Cited by 25
“An increase in IL-6 serum levels appears to be necessary to stimulate the hypothalamus [65].”
BackgroundSharpley, C. F., Bitsika, V., McMillan, M., Jesulola, E., & Agnew, L. L. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s213839 · Cited by 24
Marcelli, M., & Mediwala, S. N. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2019-001233 · Cited by 25
Hypothalamic-Pituitary-Adrenal Axis
Kyrou, I., & Tsigos, C. (2005) · Springer eBooks · doi:10.1007/3-540-26861-8_3 · Cited by 25
Self-citationExcessively high prolactin level in a patient with a nonprolactin-secreting adenoma
Albuquerque, F. C., Hinton, D. R., & Weiss, M. H. (1998) · Journal of neurosurgery · doi:10.3171/jns.1998.89.6.1043 · Cited by 19
Zogović, D., Pešić, V., Dmitrašinović, G., Dajak, M., Plećaš, B., Batinić, B., Popović, D., & Ignjatović, S. (2013) · Journal of Medical Biochemistry · doi:10.2478/jomb-2014-0016 · Cited by 23
“It is well known that IL-6 has the ability to activate the HPA axis as it can stimulate CRH release (25), and increase ACTH and cortisol level (12, 13).”
BackgroundThe effect of insulin-induced hypoglycemia on inflammatory markers: a systematic review
Drummond, J. B., Barbosa, I. G., Dantzer, R., & Teixeira, A. L. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.05.003 · Cited by 16
Stress, Endocrine Manifestations, and Diseases
Chrousos, G. P., Tsigos, C., & Kyrou, I. (2004) · CRC Press eBooks · doi:10.1201/9781420039702.ch6 · Cited by 21
Self-citationCytokine regulation of lipolysis in humans?
Jensen, M. (2003) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2003-030703 · Cited by 22
Jiang, Y., Zhang, W., Gao, F., et al. (2015) · BioOne Complete (BioOne) · doi:10.1139/cjas-2014-183 · Cited by 17
“The pro-inflammatory cytokines such as IL-1b, IL-6, and TNF-a, produced and released by macrophages, are the primary cellular messengers triggering the cascade of metabolic alterations following the innate immune response (Klasing and Johnstone 1991; Tsigos et al. 1997).”
BackgroundCorticotropin-releasing hormone regulates IL-6 expression during inflammation
Venihaki, M., Dikkes, P., Carrigan, A., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112869 · Cited by 16
van Middendorp, H., Geenen, R., Sorbi, M. J., van Doornen, L. J. P., & Bijlsma, J. W. J. (2005) · Lara D. Veeken · doi:10.1093/rheumatology/keh626 · Cited by 16
“IL-6 is a potent activator of the HPA axis [20], but in our study cortisol and noradrenaline Psychophysiology of rheumatoid arthritis 909”
Yonemura, K., Nakajima, T., Suzuki, T., Ando, S., Genma, R., Nakamura, H., & Hishida, A. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.5.668 · Cited by 16
Kılıç, M., Ulusoy, Ö., Cırrık, S., Hindistan, İ. E., & Özkaya, Y. G. (2013) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.100.2013.019 · Cited by 18
Lebaron-Jacobs, L., Wysocki, J., & Griffiths, N. M. (2004) · Radiation Research · doi:10.1667/rr3180 · Cited by 15
“Moreover, clinical tests of pituitary-adrenal function include IL6 injections (25, 26).”
BackgroundStraub, R. H. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12409 · Cited by 17
Immune Response of Laying Hens Exposed to 30 ppm Ammonia for 25 Weeks
Chen, H., Yan, F., Hu, J., Wu, Y., Tucker, C., Green-Miller, A. R., & Cheng, H. W. (2017) · International Journal of Poultry Science · doi:10.3923/ijps.2017.139.146 · Cited by 17
Hager, P., Permert, J., Wikström, A., Herrington, M. K., Östenson, C., & Strömmer, L. (2009) · Metabolism · doi:10.1016/j.metabol.2008.10.021 · Cited by 13
The prevention and treatment of sepsis: Is interleukin-6 a drug target or a drug?*
Fink, M. P. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000203108.60429.df · Cited by 19
The Role of Chicken Prolactin, Growth Hormone and Their Receptors in the Immune System
Mo, G., Hu, B., Wei, P., Luo, Q., & Zhang, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.900041 · Cited by 21
“GH can promote the IL-6 expression in the thymus, while IL-6 can stimulate hypothalamus and induce the pituitary to secrete GH (Tsigos et al., 1997).”
BackgroundKoppenol, A., Delezie, E., Parmentier, H. K., et al. (2014) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.12.006 · Cited by 11
Safety of Growth Hormone Treatment in Children with Juvenile Idiopathic Arthritis
Simon, D. (2009) · Hormone Research in Paediatrics · doi:10.1159/000229767 · Cited by 10
Meyer, M. K., & Andersen, M. (2015) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000380 · Cited by 9
“IL-6 stimulates the hepatic release of acute phase reactants, which makes the CRP concentration a surrogate marker for tocilizumab efficacy [9].”
BackgroundKreiner, F. F., & Galbo, H. (2012) · Arthritis Research & Therapy · doi:10.1186/ar4017 · Cited by 10
“This is so, because plasma cortisol levels may be lower than expected, because concentrations of various cytokines (for example, IL-6) are increased [1,3,8-11], and because in non-PMR patients, injection with IL-6 has been shown to increase ACTH and cortisol levels in plasma [3,8,11-15].”
BackgroundResultInfluentialInfluence of proinflammatory cytokine gene polymorphism on childhood obesity
Popko, K., Górska, E., Pyrżak, B., Stelmaszczyk‐Emmel, A., Wiśniewska, A., Majcher, A., Wąsik, M., & Demkow, U. A. (2009) · European journal of medical research · doi:10.1186/2047-783x-14-s4-59 · Cited by 11
“This observation may indicate that the hypothalamic hormones, through corticotropin release, can mediate both processes [16].”
BackgroundTraumatic brain injury and prolactin
Hacıoğlu, A., & Tanrıverdi, F. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09904-x · Cited by 9
Milewska-Jędrzejczak, M., & Glabinski, A. R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051880 · Cited by 11
“This mechanism mediates the anti-inflammatory effect in contrast to monocyte-secreted Il-6 [36].”
BackgroundLandau, E. R., Raniti, M. B., Blake, M. J., Waloszek, J. M., Blake, L. M., Simmons, J. G., Schwartz, O., Murray, G., Trinder, J. C., Allen, N. B., et al. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.114098 · Cited by 10
Determinants of Adrenal Androgen Hypofunction in Premenopausal Females With Rheumatoid Arthritis
Imrich, R., Vlček, M., Kerlik, J., Vogeser, M., Kirchhoff, F., Penesová, A., Rádiková, Ž., LUKÁČ, J., & Rovenský, J. (2014) · Physiological Research · doi:10.33549/physiolres.932663 · Cited by 7
“IL-6 has been considered one of the main systemic mediators of chronic inflammation in humans (Tsigos et al. 1997).”
BackgroundLiu, J., Chang, G., Huang, J., Ma, N., Wang, Y., Roy, A. C., & Shen, X. (2021) · Animal Biotechnology · doi:10.1080/10495398.2021.1919129 · Cited by 7
“Some early studies have reported that macrophages secrete pro-inflammatory cytokines such as IL1b, IL6, and TNF-a, the primary cellular messengers triggering the cascade of metabolic alterations following the innate immune response.(24,25) However, overproduction of these pro-inflammatory cytokines can be dangerous.”
BackgroundCepon‐Robins, T. J. (2015) · Scholars' Bank (University of Oregon) · Cited by 6
Shahin, D. (2011) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2011.03.001 · Cited by 5
“Hyperprolactinemia in patients with SLE may be caused by either enhanced secretion of pituitary PRL under the effect of inflammatory cytokines [26] or increased production of PRL by peripheral lymphocytes [9,27].”
BackgroundSoliman, H., Fahmy, B. S., Ali, M. G., et al. (2023) · Pediatric Rheumatology · doi:10.1186/s12969-023-00915-7 · Cited by 5
Stress, Insulin Resistance, and Type 2 Diabetes
Kyrou, I., Randeva, H. S., & Tsigos, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802175-0.00035-8 · Cited by 7
Self-citationInflammation and vasopressin hypersecretion in aging
Mutig, K., Lebedeva, S. A., & Singh, P. B. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1689787 · Cited by 6
The Interacting Neuroendocrine Network in Stress-Inducing Mood Disorders
Leff, P., Hernández, M. E., Becerril‐Villanueva, E., Martinez, C. B. D. R., Téllez-Santillán, C., Pérez-Tapia, M., Salazar, A., Antón, B., Berlanga, C., & Pavón, L. (2010) · The Open Neuroendocrinology Journal · doi:10.2174/1876528901003010180 · Cited by 6
“In same context, human studies demonstrated that prolonged administration of IL-6 yields to an adrenal enlargement [275,276] probably mediated through a direct stimulation of IL-6 receptors on adrenal cortex as shown from adrenals of mice.”
BackgroundParaadrenal Castleman disease presenting with adrenal hyperandrogenism
Müssig, K., Gallwitz, B., Machicao, F. E., Horger, M., Häring, H.-U., & KAISERLING, E. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344093 · Cited by 4
Neuroendokrin-immune Interaktionen bei rheumatischen Krankheiten
Straub, R. H., & Faßold, A. (2010) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-010-0637-x · Cited by 3
Siroen, M. P. C., de van der Schueren, M. A. E., Richir, M. C., Sauerwein, H. P., Leemans, C. R., Quak, J. J., & van Leeuwen, P. A. M. (2006) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607106030005415 · Cited by 5
Abdelaziz, M. M., Goma, S. H., Sayed, S. K., El-Hammady, D. H., Gamal, R. M., & Sayed, D. S. (2018) · Egyptian Rheumatology and Rehabilitation · doi:10.4103/err.err_18_17 · Cited by 3
Cytokines and the interaction between the neuroendocrine and immune systems
Wilkinson, M., & Brown, R. E. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139045803.014 · Cited by 8
Sajedi, D., Shabani, R., & Elmieh, A. (2021) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12673 · Cited by 3
Addy, C., Bradley, J. M., McGarvey, L. P., Elborn, J. S., & Downey, D. G. (2019) · Research Portal (Queen's University Belfast) · Cited by 4
HIV-1 Infection, Neuroendocrine Abnormalities, and Clinical Outcomes
Kumar, M., Goodkin, K., Kumar, A. M., Baldewicz, T. T., Morgan, R., & Eisdorfer, C. (2000) · CNS Spectrums · doi:10.1017/s1092852900013250 · Cited by 3
Stress and Endocrine Physiology
Nicolaides, N. C., Pervanidou, P., & Chrousos, G. P. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.03751-x · Cited by 4
Self-citationMcLeod, R. E., Kale, K. M., Weglinski, C., Masoud, A. M., Akbar, N., Probert, F., Anthony, D. C., & Zainal, J. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.07.027 · Cited by 2
Origin of Typical Disease Sequelae
Straub, R. H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-803321-0.00005-7 · Cited by 3
Pheochromocytoma presenting as fever of unknown origin, a case report
Clavijo, A. ́. G., Loaiza, J. D. M., Guzmán-Rojas, J. D. D., et al. (2020) · Case reports · doi:10.15446/cr.v6n2.84240 · Cited by 2
“IL-6 is an endogenous pyrogen that has the capacity to activate the hypothalamic–pituitary–adrenal axis at each of its central levels (4-7) and to stimulate the secretion of glucocorticoids directly in the adrenal cortex.”
BackgroundFriedman, T. C. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-101-5_15 · Cited by 2
The Neuroimmune System in Psychiatric Disorders
Murrin, L. C., & Thomas, M. P. (2008) · Springer eBooks · doi:10.1007/978-0-387-72573-4_34 · Cited by 2
“Several pro-inflammatory cytokines, including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6), can activate the HPA axis (Chrousos, 1995; Tsigos et al., 1997 ).”
BackgroundSystemic stress response and hyperglycemia after abdominal surgery in rat and man
Hager, P. (2008) · Figshare · Cited by 2
Straub, R. H. (2024) · Springer eBooks · doi:10.1007/978-3-662-68904-2_4 · Cited by 1
New Aspects of the Immunoregulation by the Hypothalamo-Pituitary-Adrenal (HPA) Axis
Vecsernyés, M., Kovács, K., Tóth, B. E., Welke, L., & Nagy, G. M. (2012) · Advances in Neuroimmune Biology · doi:10.3233/nib-012907 · Cited by 1
Moon, S., Lee, S. H., Jung, B.-H., & Min, J. (2017) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2017.24.4.192 · Cited by 1
“In healthy subjects, there was a dose-response relationship between serum concentrations of inflammatory cytokine and cortisol level [33].”
BackgroundImmunologisches und energiespeicherndes Gedächtnis
Straub, R. H. (2019) · Springer eBooks · doi:10.1007/978-3-662-59131-4_9 · Cited by 1
Neuroendocrine Involvement in Immune-Mediated Rheumatic Diseases
Cutolo, M., & Trombetta, A. C. (2019) · Endocrinology · doi:10.1007/978-3-319-66362-3_9-1 · Cited by 1
Roelfsema, F., Yang, R. J., & Veldhuis, J. D. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab484 · Cited by 1
Neuroendocrine Involvement in Immune-Mediated Rheumatic Diseases
Cutolo, M., & Trombetta, A. C. (2020) · Endocrinology · doi:10.1007/978-3-319-68729-2_9 · Cited by 1
González-Muñiz, O. E., Jacobo-Delgado, Y. M., Félix-Arellano, C., Serrano, C. J., & Rivas-Santiago, B. T. (2024) · TIP Revista Especializada en Ciencias Químico-Biológicas · doi:10.22201/fesz.23958723e.2024.666
“Se observó el mismo efecto con la IL-6, que induce valores máximos de la ACTH y el cortisol a los 90 y 120 minutos respectivamente, por lo que retorna a sus valores basales entre 4-6 horas (Tsigos et al. , 1997).”
BackgroundPathogenesis and Neuroendocrine Immunology
Straub, R. H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-803321-0.00002-1 · Cited by 1
Docrat, A. (2008) · ResearchSpace (University of KwaZulu-Natal) · Cited by 1
Zhou, W., Diemer, T., Xin, H., Ginne, K. C., N, N. K. R., Mori, T., Biswas, N., Piermarocchi, C., & Ferrara, N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.24.707802 · Cited by 1
“Similar biphasic dynamics have been described for LIF (26, 34), other IL6 family cytokines (36, 49), as well as VEGF (46), underscoring the importance of dose in translating cytokine signals into effective outcomes with safety.”
Romas (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200004)43:4
Self-citationImportance of cytokine metabolism for malnutrition, catabolism and endocrinological state in sepsis
Roth, E., & Bergmann, M. M. (1999) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8755-7_13 · Cited by 2
Rembold, V. (2015) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.18460
Growth Hormone Response to Exercise: Implications for Body Growth
Galassetti, P. R., & Pablico, P. C. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1795-9_147
Lundgren, M. (2006) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 1
Aa, B., Alexeeva, E. I., Namazova-Baranova, L. S., Бзарова, Т. М., Valiyeva, S., Denisova, R. V., Isayeva, K., Чомахидзе, А. М., Chistyakova, Е. G., Sleptsova, T. V., et al. (2012) · InTech eBooks · doi:10.5772/48761
Inflammatory Mediator Action on the Anterior Pituitary Gland
Giacomini, D., Acuña, M., Nagashima, A. C., Castro, C. P., Páez-Pereda, M., Renner, U., Stalla, G. K., & ARZT, E. S. (2007) · Neuroimmune biology · doi:10.1016/s1567-7443(07)00213-x
The Effect of Manipulating the IL-6 Response to Exercise on Biomarkers and Exercise Performance
Walshe, I. H. (2012) · Northumbria Research Link (Northumbria University)
Procalcitonina e interleicina-6 em crianças com diagnóstico de sepse e choque séptico
Fioretto, J. R. (2006) · Acervo Digital da Universidade Estadual Paulista (Universidade Estadual Paulista)
Metadata
- Authors
- Tsigos, C., Papanicolaou, D. A., Defensor, R., Mitsiadis, C. S., Kyrou, I., & Chrousos, G. P.
- Affiliations
- National Institutes of Health (US)
- National and Kapodistrian University of Athens (GR)
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2008-04-09
- Volume
- 66
- Issue
- 1
- Pages
- 54-62
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2081153263
- Cited by
- 223
- References
- 0
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 5 · 2021: 7 · 2020: 4 · 2019: 6 · 2018: 6 · 2017: 7 · 2016: 7 · 2015: 14 · 2014: 11 · 2013: 6 · 2012: 12
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Neuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- interleukin-6, dose-response relationship, pituitary hormone secretion, resting metabolic rate, energy expenditure, ACTH, cortisol, growth hormone, prolactin, thyroid-stimulating hormone, gonadotropins, hypothalamic-pituitary-adrenal axis, cytokines, vasopressin, corticotropin-releasing factor
- MeSH terms
- Adrenocorticotropic Hormone, Adult, Arginine Vasopressin, Basal Metabolism, Calorimetry, Indirect, Dose-Response Relationship, Drug, Energy Metabolism, Humans, Hydrocortisone, Kinetics, Male, Pituitary Hormones, Prolactin, Recombinant Proteins, Thyrotropin, Interleukin-6, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.